{"schema_version":"1","generated_at":"2026-11-19T04:15:48.625Z","data_as_of":null,"url":"https://www.findmykol.com/kol/evelyn-reynolds","json_url":"https://www.findmykol.com/kol/evelyn-reynolds/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"evelyn-reynolds","name":"Evelyn Reynolds","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Mayo Clinic","institution_url":"https://www.findmykol.com/institution/mayo-clinic","city":"Rochester","state":"MN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1265465140","orcid":"0009-0006-6818-2412","openalex":"A5014020004"},"summary":"Evelyn Reynolds is an Oncology physician affiliated with Mayo Clinic. OpenAlex indexes 36 publications with 261 citations (h-index 10); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":36,"cited_by_count":261,"h_index":10,"latest_activity_year":2026,"emerging":true,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07062016","title":"Molecular and ctDNA Characterization of High-Risk Endometrial Cancer","status":"RECRUITING","role":"Overall official","sponsor":"Mayo Clinic","source_url":"https://clinicaltrials.gov/study/NCT07062016","trial_url":"https://www.findmykol.com/trial/NCT07062016"}],"source":"trials"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":13,"shown":3,"withheld":10,"rows":[{"payer":"Fennec Pharmaceuticals, Inc.","program_year":2024,"amount_usd":48.91,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265465140"},{"payer":"GlaxoSmithKline, LLC.","program_year":2022,"amount_usd":132.6,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265465140"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2022,"amount_usd":67.65,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265465140"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265465140","source":"payments"},"prescribing":{"data_year":2022,"areas_total":4,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":78.9,"classes_total":4,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":35.5,"drugs":[{"name":"Oxycodone-Acetaminophen","share_pct":100}],"max_beneficiaries":62},{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":26.6,"drugs":[{"name":"Ibuprofen","share_pct":100}],"max_beneficiaries":45}]},{"area":"Metabolism & gastrointestinal","share_pct":10.5,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":10.5,"drugs":[{"name":"Ondansetron Hcl","share_pct":100}],"max_beneficiaries":21}]},{"area":"Genitourinary & hormones","share_pct":5.9,"classes_total":1,"classes":[{"class":"Estrogen","setting":"prescribed","share_pct":5.9,"drugs":[{"name":"Estradiol","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2022,"office_pct":81.5,"facility_pct":18.5},"source":"medicare"},"publications":{"total":36,"shown":5,"withheld":31,"matched_by":"OpenAlex author record","recent":[{"title":"Prognostic value of perioperative circulating tumor DNA (ctDNA) in endometrial cancer with high-risk features: a prospective observational study","year":2026,"journal":"European Journal of Surgical Oncology","source_url":"https://doi.org/10.1016/j.ejso.2026.111388","status":"verified"},{"title":"Lymphovascular Space Invasion in Stage I Endometrial Cancer: Does Quantity Matter?","year":2026,"journal":"International Journal of Gynecological Cancer","source_url":"https://doi.org/10.1016/j.ijgc.2026.105650","status":"verified"},{"title":"Delays to initial evaluation drive socioeconomic care disparities in endometrial cancer","year":2026,"journal":"Gynecologic Oncology Reports","source_url":"https://doi.org/10.1016/j.gore.2026.102204","status":"verified"},{"title":"Innovation through standardization: Reducing the ileostomy rates while targeting zero anastomotic leaks at cytoreductive surgery","year":2026,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2026.05.009","status":"verified"},{"title":"ONCOLOGIC OUTCOMES OF THE SENTINEL LYMPH NODE MAPPING ALGORITHM IN SURGICALLY STAGED AGGRESSIVE ENDOMETRIAL CANCER ACCORDING TO HISTOLOGIC SUBTYPE: A RETROSPECTIVE STUDY","year":2026,"journal":"International Journal of Gynecological Cancer","source_url":"https://doi.org/10.1016/j.ijgc.2026.105428","status":"verified"}],"source":"works"},"similar":[{"name":"Bernard Gersh","slug":"bernard-gersh","institution":"Mayo Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/bernard-gersh","json_url":"https://www.findmykol.com/kol/bernard-gersh/profile.json"},{"name":"Bradley Boeve","slug":"bradley-boeve","institution":"Mayo Clinic","specialty":"Neurology","url":"https://www.findmykol.com/kol/bradley-boeve","json_url":"https://www.findmykol.com/kol/bradley-boeve/profile.json"},{"name":"S. Vincent Rajkumar","slug":"s-rajkumar","institution":"Mayo Clinic","specialty":"Hematology","url":"https://www.findmykol.com/kol/s-rajkumar","json_url":"https://www.findmykol.com/kol/s-rajkumar/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":10,"publications":31}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}